Business Description
Bolt Biotherapeutics is a clinical-stage company focused on developing new cancer treatments that harness the body's immune system. Their work centers on a range of experimental therapies targeting several cancer types, including stomach, lung, pancreatic, and breast cancers. The company works alongside partners such as Genmab, Toray Industries, and Innovent Biologics, and holds a licensing agreement with Stanford University. Founded in 2015 and based in Redwood City, California, Bolt Biotherapeutics aims to advance cancer care through innovative immune-based approaches.
